Arcutis Biotherapeutics, Inc. (ARQT) Technical Analysis & Indicators
Arcutis Biotherapeutics, Inc. (ARQT) — Price $32.07 (closing price, October 30, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Arcutis Biotherapeutics, Inc. (ARQT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds.